Skip to main content
TipRanks
Go Ultimate75% OFF

LAWRENCE STEINMAN Insider Profile

11 Followers

LAWRENCE STEINMAN, Director at Pasithea Therapeutics Corp, holds 199.69K shares in Pasithea Therapeutics Corp (Ticker: KTTA), holds 112.49K shares in Forum Markets (Ticker: FRMM), holds 78.46K shares in BioAtla (Ticker: BCAB). Most recently, LAWRENCE STEINMAN Bought ― shares of Pasithea Therapeutics Corp on Dec 01, 2025 for an estimated value of $100.00K.

LAWRENCE STEINMAN's Trading History

KTTA
Pasithea Therapeutics Corp
Dec 01, 2025DirectorInformative Buy100.00K$104.24K
FRMM
Forum Markets
Jun 20, 2025DirectorUninformative Buy―$242.98K
BCAB
BioAtla
Jun 18, 2025DirectorUninformative Buy―$122.40K
BCEL
Atreca
Jun 24, 2019―Uninformative Buy―$23.26K

You May Also Like

LAWRENCE STEINMAN insider profile FAQ

What is the percentage of profitable transactions made by LAWRENCE STEINMAN?
The percentage of profitable transactions made by LAWRENCE STEINMAN is 0%.
What is the average return per transaction made by LAWRENCE STEINMAN?
The average return per transaction made by LAWRENCE STEINMAN is -64.40%.
What stocks does LAWRENCE STEINMAN hold?
LAWRENCE STEINMAN holds: KTTA, FRMM, BCEL, BCAB stocks.
What was LAWRENCE STEINMAN’s latest transaction?
LAWRENCE STEINMAN’s latest transaction was an Informative Buy of $100.00K.
What was LAWRENCE STEINMAN's most profitable transaction?
LAWRENCE STEINMAN’s most profitable transaction was an Informative Buy of BCAB stock on December 19, 2023. The return on the trade was -40.30%.
What is LAWRENCE STEINMAN's role in Pasithea Therapeutics Corp?
LAWRENCE STEINMAN's role in Pasithea Therapeutics Corp is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.